- Home
- RPRX vs NVT Comparison
RPRX vs NVT Comparison
Compare RPRX & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- NVT
- Stock Information
- Founded
- RPRX 1996
- NVT 1903
- Country
- RPRX United States
- NVT United Kingdom
- Employees
- RPRX N/A
- NVT N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- NVT Industrial Machinery/Components
- Sector
- RPRX Health Care
- NVT Industrials
- Exchange
- RPRX Nasdaq
- NVT Nasdaq
- Market Cap
- RPRX 13.9B
- NVT 11.5B
- IPO Year
- RPRX 2020
- NVT N/A
- Fundamental
- Price
- RPRX $36.03
- NVT $73.33
- Analyst Decision
- RPRX Strong Buy
- NVT Strong Buy
- Analyst Count
- RPRX 3
- NVT 9
- Target Price
- RPRX $47.33
- NVT $70.33
- AVG Volume (30 Days)
- RPRX 4.3M
- NVT 1.6M
- Earning Date
- RPRX 08-07-2025
- NVT 08-05-2025
- Dividend Yield
- RPRX 2.44%
- NVT 1.09%
- EPS Growth
- RPRX 37.60
- NVT 1.65
- EPS
- RPRX 2.45
- NVT 3.49
- Revenue
- RPRX $2,263,845,000.00
- NVT $3,083,300,000.00
- Revenue This Year
- RPRX $29.35
- NVT $19.79
- Revenue Next Year
- RPRX $7.58
- NVT $9.30
- P/E Ratio
- RPRX $14.72
- NVT $20.99
- Revenue Growth
- RPRX 1.13
- NVT 15.90
- 52 Week Low
- RPRX $24.05
- NVT $41.71
- 52 Week High
- RPRX $36.32
- NVT $81.55
- Technical
- Relative Strength Index (RSI)
- RPRX 64.81
- NVT 69.36
- Support Level
- RPRX $35.01
- NVT $68.60
- Resistance Level
- RPRX $36.14
- NVT $74.75
- Average True Range (ATR)
- RPRX 0.70
- NVT 1.67
- MACD
- RPRX 0.10
- NVT 0.10
- Stochastic Oscillator
- RPRX 90.07
- NVT 76.79
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About NVT nVent Electric plc
nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.